Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1B1

Drug Metabolism and Disposition

Volumn 32, Issue 8, 2004, Pages 840-847

  Choudhary, Dharamainder ^a   Jansson, Ingela ^a   Stoilov, Ivaylo ^a   Sarfarazi, Mansoor ^a   Schenkman, John B ^a,b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b MC1505 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 1B1; DIMETHYLBENZ[A]ANTHRACENE; EPOXYICOSATRIENOIC ACID; HEMOPROTEIN; HYDROXYICOSATETRAENOIC ACID; POLYCYCLIC AROMATIC HYDROCARBON; RETINAL; RETINOID; RETINOL;

AEROBIC METABOLISM; ARTICLE; CATALYSIS; CHEMICAL MODIFICATION; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; MOUSE; NONHUMAN; ORTHOLOGY; OXIDATION; PRIORITY JOURNAL; PROTEIN FUNCTION; XENOBIOTIC METABOLISM;

ANIMALS; ARACHIDONIC ACID; ARYL HYDROCARBON HYDROXYLASES; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MICE; RETINOIDS;

EID: 3242682298     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.32.8.840     Document Type: Article

References (42)

1. Brash AR, Boeglin WE, Capdevila JH, Yeola S, and Blair IA (1995) 7-HETE, 10-HETE, and 13-HETE are major products of NADPH-dependent arachidonic acid metabolism in rat liver microsomes: analysis of their stereochemistry and the stereochemistry of their acid-catalyzed rearrangement. Arch Biochem Biophys 321:485-492.
2. Bylund J, Bylund M, and Oliw EH (2001) cDNA cloning and expression of CYP4F12, a novel human cytochrome P450. Biochem Biophys Res Commun 280:892-897.
3. Bylund J, Kunz T, Valmsen K, and Oliw EH (1998) Cytochromes P450 with bisallylic hydroxylation activity on arachidonic and linoleic acids studied with human recombinant enzymes and with human and rat liver microsomes. J Pharmacol Exp Ther 284:51-60.
4. Capdevila JH and Falck JR (2001) The CYP P450 arachidonic acid monooxygenases: from cell signaling to blood pressure regulation. Biochem Biophys Res Commun 285:571-576.
5. Chambon P (1996) A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954.
6. Chen H, Howald WN, and Juchau MR (2000) Biosynthesis of all-trans-retinoic acid from all-trans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug Metab Dispos 28:315-322.
7. Daikh BE, Lasker JM, Raucy JL, and Koop DR (1994) Regio- and stereoselective epoxidation of arachidonic acid by human cytochromes p450 2C8 and 2C9. J Pharmacol Exp Ther 271:1427-1433.
8. Falck JR, Lumin S, Blair I, Dishman E, Martin MV, Waxman DJ, Guengerich FP, and Capdevila JH (1990) Cytochrome P-450-dependent oxidation of arachidonic acid to 16-, 17- and 18-hydroxyeicosatetraenoic acids. J Biol Chem 265:10244-10249.
9. Fisher CW, Caudle DL, Martin-Wixtrom C, Quattrochi LC, Tukey RH, Waterman MR, and Estabrook RW (1992) High-level expression of functional human cytochrome-P450 1A2 in Escherichia coli. FASEB J 6:759-764.
10. Fujii H, Sato T, Kaneko S, Gotoh O, Fujii-Kuriyama Y, Osawa K, Kato S, and Hamada H (1997) Metabolic inactivation of retinoic acid by a novel P450 differentially expressed in developing mouse embryos. EMBO J 16:4163-4173.
11. Gotoh O (1992) Substrate recognition sites in cytochrome-P450 family-2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem 267:83-90.
12. Hashizume T, Imaoka S, Hiroi T, Terauchi Y, Fujii T, Miyazaki H, Kamataki T, and Funae Y (2001) cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine. Biochem Biophys Res Commun 280:1135-1141.
13. Jansson I, Stoilov I, Sarfarazi M, and Schenkman JB (2000) Enhanced expression of CYP1B1 in Escherichia coli. Toxicology 144:211-219.
14. Jansson I, Stoilov I, Sarfarazi M, and Schenkman JB (2001) Effect of two mutations of human CYP1B1, G61E and R469W, on stability and endogenous steroid substrate metabolism, Pharmacogenetics 11:793-801.
15. 2 in vascular smooth muscle cells. J Pharmacol Exp Ther 304:761-772.
16. Keeney DS, Skinner C, Traverse JB, Capdevila JH, Nanney LB, King LE Jr, and Waterman MR (1998) Differentiating keratinocytes express a novel cytochrome P450 enzyme, CYP2B19, having arachidonate monooxygenase activity. J Biol Chem 273:32071-32079.
17. Leo MA, Lasker JM, Raucy JL, Kim C-I, Black M, and Lieber C (1989) Metabolism of retinol and retinoic acid by human liver cytochrome P450IIC8. Arch Biochem Biophys 269:305-312.
18. Lewis DFV, Gillam EMJ, Everett SA, and Shimada T (2003) Molecular modeling of human CYP1B1 substrate interactions and investigation of allelic variant effects on metabolism. Chem-Biol Interact 145:281-295.
19. Luo G, Zeldin DC, Blaisdell JA, Hodgson E, and Goldstein JA (1998) Cloning and expression of murine Cyp2cs and their ability to metabolize arachidonic acid. Arch Biochem Biophys 357:45-57.
20. Ma YH, Gebremedhin D, Schwartzman ML, Falck JR, Clark JE, Masters BS, Harder DR, and Roman RJ (1993) 20-Hydroxyeicosatetraenoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries. Circ Res 72:126-136.
21. Maden M (1999) Heads or tails? Retinoic acid will decide. BioEssays 21:809-812.
22. Marill J, Cresteil T, Lanotte M, and Chabot GG (2000) Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites. Mol Pharmacol 58:1341-1348.
23. McGiff JC (1991) Cytochrome P-450 metabolism of arachidonic acid. Annu Rev Pharmacol Toxicol 31:339-369.
24. McSorley LC and Daly AK (2000) Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation. Biochem Pharmacol 60:517-526.
25. O'Flaherty JT, Rogers LC, Chadwell BA, Owen JS, Rao A, Cramer SD, and Daniel LW (2002) 5(S)-Hydroxy-6,8,11,14-E,Z,Z,Z-eicosatetraenoate stimulates PC3 cell signaling and growth by a receptor-dependent mechanism. Cancer Res 62:6817-6819.
26. Pottenger LH, Christou M, and Jefcoate CR (1991) Purification and immunological characterization of a novel cytochrome-P450 from C3H/10T1/2 cells. Arch Biochem Biophys 286:488-497.
27. Powell PK, Wolf I, Jin R, and Lasker JM (1998) Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. J Pharmacol Exp Ther 285:1327-1336.
28. Rifkind AB, Lee C, Chang TK, and Waxman DJ (1995) Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1 and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes. Arch Biochem Biophys 320:380-389.
29. Roberts ES, Vaz ADN, and Coon MJ (1992) Role of isozymes of rabbit microsomal cytochrome P-450 in the metabolism of retinoic acid, retinol and retinal. Mol Pharmacol 41:427-433.
30. Savas U, Carstens C-P, and Jefcoate CR (1997) Biological oxidations and P450 reactions. Recombinant mouse CYP1B1 expressed in Escherichia coli exhibits selective binding by polycyclic hydrocarbons and metabolism which parallels C3H10T1/2 cell microsomes, but differs from human recombinant CYP1B1. Arch Biochem Biophys 347:181-192.
31. Schenkman JB, Choudhary D, Jansson I, Sarfarazi M, and Stoilov I (2003) Involvement of cytochromes P450 in development. Proc Indian Natl Sci Acad Part B Biol Sci B69:929-941.
32. Schenkman JB and Jansson I (1998) Spectral analysis of cytochrome P450, in Methods in Molecular Biology: Cytochrome P450 Protocols (Phillips IR and Shephard EA eds), pp 25-33, Humana Press, Totowa, NJ.
33. +-ATPase in the cornea. Proc Natl Acad Sci USA 84:8125-8129.
34. Shankaranarayanan P and Nigam S (2003) IL-4 induces apoptosis in A549 lung adenocarcinoma cells: evidence for the pivotal role of 15- hydroxyeicosatetraenoic acid binding to activated peroxisome proliferator-activated receptor gamma transcription factor. J Immunol 170:887-894.
35. Shimada T, Wunsch RM, Hanna IH, Sutter TR, Guengerich FP, and Gillam EMJ (1998) Recombinant human cytochrome P450 1B1 expression in Esherichia coli. Arch Biochem Biophys 357:111-120.
36. Smith G, Wolf CR, Deeni YY, Dawe RS, Evans AT, Comrie MM, Ferguson J, and Ibbotson SH (2003) Cutaneous expression of cytochrome P450 CYP2S1: individuality in regulation by therapeutic agents for psoriasis and other skin diseases. Lancet 361:1336-1343.
37. Stoilov I, Jansson I, Sarfarazi M, and Schenkman JB (2001) Roles of cytochrome P450 in development. Drug Metab Drug Interact 18:1-23.
38. Swindell EC, Thaller C, Sockanathan S, Petkovich M, Jessell TM, and Eichele G (1999) Complementary domains of retinoic acid production and degradation in the early chick embryo. Dev Biol 216:282-296.
39. Vanden Bossche H, Willemsens G, and Janssen PAJ (1988) Cytochrome P-450-dependent metabolism of retinoic acid in rat skin microsomes: inhibition by ketoconazole. Skin Pharmacol 1:176-185.
40. Wen Y, Gu J, Knaus UG, Thomas L, Gonzales N, and Nadler JL (2000) Evidence that 12-lipoxygenase product 12-hydroxyeicosatetraenoic acid activates p21-activated kinase. Biochem J 349:481-487.
41. Wu S, Moomaw CR, Tomer KB, Falck JR, and Zeldin DC (1996) Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart. J Biol Chem 271:3460-3468.
42. Zhang QY, Dunbar D, and Kaminsky L (2000) Human cytochrome P-450 metabolism of retinals to retinoic acids. Drug Metab Dispos 28:292-297.